EVALUATION OF 2 INTRAVENOUS THROMBOLYTIC AGENTS (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS STREPTOKINASE) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引：5
|
作者：
SEABRAGOMES, R
SILVA, JA
ALEIXO, A
REAL, T
FREIRE, I
TORRES, I
FREITAS, R
CRESPO, F
机构：
来源：
DRUGS | 1987年 / 33卷
关键词：
D O I：
10.2165/00003495-198700333-00028
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：169 / 174
页数：6
相关论文
共 50 条
  • [31] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [32] HEMATOLOGICAL EFFECTS OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX AND STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT OF THE IRS-II STUDY
    MONASSIER, JP
    HANSSEN, M
    DRUGS, 1987, 33 : 247 - 252
  • [33] SUMMARY OF EARLY CLINICAL-EXPERIENCE WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    JACKSON, D
    DRUGS, 1987, 33 : 104 - 111
  • [34] ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS PLACEBO - A PRELIMINARY MULTICENTER STUDY OF SAFETY AND EARLY MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    JULIAN, DG
    BORTHWICK, LS
    REID, D
    JENNINGS, KP
    WAINWRIGHT, RJ
    RODGER, JC
    WOOD, D
    PHILLIPS, WS
    DRUGS, 1987, 33 : 261 - 267
  • [35] ANALYSIS OF COAGULATION AND FIBRINOLYSIS AFTER INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX OR HEPARIN IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A BELGIAN MULTICENTER STUDY
    RENKIN, J
    COLDEBEYS, C
    LAVENNEPARDONGE, E
    PINTENS, H
    COL, J
    DRUGS, 1987, 33 : 253 - 260
  • [36] THE EFFECT OF THROMBOLYTIC THERAPY WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON THE INDICATORS OF MYOCARDIAL SALVAGE
    BUCHALTER, MB
    BOURKE, JP
    JENNINGS, K
    ADAMS, PC
    KENMURE, ACF
    HAH, CW
    REID, DS
    DRUGS, 1987, 33 : 209 - 215
  • [37] MULTICENTER RANDOMIZED STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) VERSUS INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION - DEPENDENCE OF REPERFUSION ON TIME TO TREATMENT AND INITIAL FLOW GRADE
    HACKWORTHY, RA
    ANDERSON, JL
    ROTHBARD, RL
    SORENSEN, SG
    FITZPATRICK, PG
    MENLOVE, RL
    BARRY, WH
    MARDER, VJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 371 - 371
  • [38] CORONARY THROMBOLYSIS DURING ACUTE MYOCARDIAL-INFARCTION BY INTRAVENOUS BRL-26921, A NEW ANISOYLATED PLASMINOGEN-STREPTOKINASE ACTIVATOR COMPLEX
    KASPER, W
    MEINERTZ, T
    WOLLSCHLAGER, H
    BONZEL, T
    WOLFF, P
    DREXLER, H
    HOFMANN, T
    ZEIHER, A
    JUST, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (06): : 418 - 421
  • [39] ACHIEVEMENT OF CORONARY-ARTERY PATENCY BY USE OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN ACUTE MYOCARDIAL-INFARCTION
    HILLIS, WS
    HORNUNG, RS
    HOGG, KJ
    HOCKINGS, N
    BURNS, JMA
    DUNN, FG
    DRUGS, 1987, 33 : 117 - 123
  • [40] EVALUATION OF THE EFFICACY AND SAFETY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN EARLY MYOCARDIAL-INFARCTION - PRELIMINARY-RESULTS
    LENHOFF, SJ
    HORAK, AR
    FRASER, RC
    SCOTTMILLAR, RN
    BIRD, AR
    JACOBS, P
    COMMERFORD, PJ
    DRUGS, 1987, 33 : 186 - 188
12345